Tse-Ming Hong

Professor

Institute of Clinical Medicine

Emailtmhong@mail.ncku.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2001 PhD, Institute of Molecular Medicine, National Taiwan University college of Medicine

Experience

2001.08~2004.07 Assistant Professor /School of Pharmacy, College of Medicine, NTU
2008.08~2012.07 Associate Professor/Institute of Clinical Medicine, NCKU
2004.08~2007.07 Assistant Researcher/Center of Genomic Medicine, NTU
2012.8~Present Professor

Research Interests

Biology of cancer
Molecular biology
Cell biology

Fingerprint

Dive into the research topics where Tse-Ming Hong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
16 Finished

探討侵襲性癌細胞分泌的胞外泌體內的長鏈非編碼核糖核酸在肺癌轉移的角色
Hong, T.
20-08-01 → 21-07-31
Project: Research project
探討侵襲性癌細胞分泌的胞外泌體內的長鏈非編碼核糖核酸在肺癌轉移的角色
Hong, T.
19-08-01 → 20-07-31
Project: Research project
探討侵襲性癌細胞分泌的胞外泌體內的長鏈非編碼核糖核酸在肺癌轉移的角色
Hong, T.
18-07-31 → 19-08-01
Project: Research project
探討Alpha-catulin在癌症幹細胞特性的角色以及作為治療標的之可能性
Hong, T.
17-08-01 → 18-07-31
Project: Research project
探討去泛素化?USP5在肺癌轉移的角色以及作為治療標的之可能性
Hong, T.
17-08-01 → 18-07-31
Project: Research project

3308 Citations
29 h-Index
64 Article
1 Comment/debate
1 Review article

DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression
Wu, J., Wu, Y., Tung, C., Tsai, Y., Chen, H., Chen, Y. & Hong, T., 2020 Jan 1, In: Theranostics. 10, 19, p. 8903-8923
Research output: Contribution to journal › Article › peer-review
DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression
Wu, J. E., Wu, Y. Y., Tung, C. H., Tsai, Y. T., Chen, H. Y., Chen, Y. L. & Hong, T. M., 2020, In: Theranostics. 10, 19, p. 8903-8923 21 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Citation (Scopus)
MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer
Tung, C. H., Kuo, L. W., Huang, M. F., Wu, Y. Y., Tsai, Y. T., Wu, J. E., Hsu, K. F., Chen, Y. L. & Hong, T. M., 2020 Jan 23, In: Oncogene. 39, 4, p. 862-876 15 p.
Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus)
Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference
Kuo, T. C., Huang, K. Y., Yang, S. C., Wu, S., Chung, W. C., Chang, Y. L., Hong, T. M., Wang, S. P., Chen, H. Y., Hsiao, T. H. & Yang, P. C., 2020 Sep 25, In: Molecular Therapy - Oncolytics. 18, p. 189-201 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin
Lin, M. S., Hong, T. M., Chou, T. H., Yang, S. C., Chung, W. C., Weng, C. W., Tsai, M. L., Cheng, T. J. R., Chen, J. J. W., Lee, T. C., Wong, C. H., Chein, R. J. & Yang, P. C., 2019 Nov 1, In: European Journal of Medicinal Chemistry. 181, 111584.
Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)